12-131828606-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016155.7(MMP17):āc.112G>Cā(p.Ala38Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000027 in 740,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016155.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMP17 | NM_016155.7 | c.112G>C | p.Ala38Pro | missense_variant | 1/10 | ENST00000360564.5 | NP_057239.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMP17 | ENST00000360564.5 | c.112G>C | p.Ala38Pro | missense_variant | 1/10 | 1 | NM_016155.7 | ENSP00000353767.1 | ||
MMP17 | ENST00000535004.2 | n.112G>C | non_coding_transcript_exon_variant | 1/10 | 3 | ENSP00000445620.2 | ||||
MMP17 | ENST00000545671.6 | n.112G>C | non_coding_transcript_exon_variant | 1/4 | 3 | ENSP00000444603.2 | ||||
MMP17 | ENST00000545790.6 | n.112G>C | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000441710.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000270 AC: 2AN: 740574Hom.: 0 Cov.: 10 AF XY: 0.00 AC XY: 0AN XY: 349762
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.112G>C (p.A38P) alteration is located in exon 1 (coding exon 1) of the MMP17 gene. This alteration results from a G to C substitution at nucleotide position 112, causing the alanine (A) at amino acid position 38 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at